polyhydroxybutyrate (PHB)/kappa-carrageenan (KCG) |
400 mg of PHB in 8 ml of HFIP |
100 mg of KCG in 2 ml of CHCl3
|
poly(hydroxybutyrate-co-valerate) (PHBV)/KCG |
1200 mg of PHBV in 8 ml of HFIP |
300 mg of KCG in 2 ml of CHCl3
|
polydioxanone (PDX)/fucoidan (FUC) |
1400 mg of PDX in 9 ml of HFIP |
350 mg of FUC in 1 ml of DMF |
PDX/KCG |
1200 mg of PDX in 7 ml of HFIP |
300 mg of KCG in 3 ml of CHCl3
|
PDX/PHBV |
800 mg of PDX and 200 mg of PHBV were dissolved in 10 ml of HFIP |
PDX/polysucrose (PSuc) |
960 mg of PDX and 240 mg of PSuc were dissolved in 10 ml of HFIP |
poly-l-lactic acid (PLLA)/PSuc |
800 mg of PLLA and 200 mg of PSuc were dissolved in 10 ml of HFIP |
PLLA/cellulose acetate (CA) |
800 mg of PLLA in 8 ml of HFIP |
200 mg of CA in 2 ml of HFIP |
PDX/CA |
800 mg of PDX in 6.7 ml of HFIP |
200 mg of CA in 1.7 ml of HFIP |
PLLA/CA 1% nanosilica |
to a 80/20 solution of PLLA/cellulose acetate, 1% nanosilica (10 mg) was added and allowed to stir overnight |
PDX/CA 1% nanosilica |
to a 80/20 solution of PDX/cellulose acetate, 1% nanosilica (10 mg) was added and allowed to stir overnight |